Barbados vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin

Barbados
0
in 2021
Saint Vincent and the Grenadines
0
in 2021
Barbados rank
146th
Saint Vincent and the Grenadines rank
146th

The number of people with susceptibility test result for rifampicin over time

  • Barbados
  • Saint Vincent and the Grenadines
051015201720192021

How they compare

Barbados currently reports 0 against 0 in Saint Vincent and the Grenadines, a difference of 0.

Across all 5 years both countries report, Saint Vincent and the Grenadines has been ahead every year.

Barbados ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.

Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Barbados Saint Vincent and the Grenadines Difference Ahead
2010s 0 3.33 3.33 Saint Vincent and the Grenadines
2020s 1 6.5 5.5 Saint Vincent and the Grenadines

Averages of every year both report within each decade.

Frequently asked questions

Which has higher the number of people with susceptibility test result for rifampicin, Barbados or Saint Vincent and the Grenadines?
Barbados, at 0 against 0 in Saint Vincent and the Grenadines as of 2021.
What is the difference in the number of people with susceptibility test result for rifampicin between Barbados and Saint Vincent and the Grenadines?
0, with Barbados ahead.
How many years of comparable data are there for Barbados and Saint Vincent and the Grenadines?
5 years are reported by both, from 2017 to 2021.
How do Barbados and Saint Vincent and the Grenadines rank globally for the number of people with susceptibility test result for rifampicin?
Barbados ranks 146th and Saint Vincent and the Grenadines ranks 146th of 155 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Barbados vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/barbados/st-vincent-and-the-grenadines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/barbados/st-vincent-and-the-grenadines/">Barbados vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed